Menarini is the largest Italian multinational biopharmaceutical company with nearly 17,000 employees worldwide and a presence in more than 100 countries, including Europe, Africa, Middle East, Asia-Pacific, Central and Latin America. With revenue in excess of USD4.4 Billion in 2012, Menarini ranks 16th among pharmaceutical companies in Europe and 38th among companies worldwide.
Menarini’s aim is to conduct world class research and develop innovative medicines, making them available to patients all around the world.
Menarini was founded in 1886 and has developed into a global biopharmaceutical powerhouse with particular strengths in R&D, Manufacturing and Diagnostics, thus offering high quality healthcare solutions to doctors and patients. Menarini also posseesses a strong tradition in partnering.
Menarini’s research programmes focus especially on the following therapeutic fields:
- Antibiotics and respiratory drugs
- Products for the treatment of diabetes
For more information about Menarini Group, visit www.menarini.com